2018 Clinic Nuclear Medicine 
AuntMinnie
OCTOBER 25, 2024
Most Influential Radiology Researcher Erik Middlebrooks, MD, Mayo Clinic, Jacksonville, FL Erik Middlebrooks, MD. One of this year's nominations for Most Influential Radiology Researcher is Erik Middlebrooks, MD, of the Mayo Clinic in Jacksonville, FL. In 2018 he received an endowed professorship from the university.
AuntMinnie
NOVEMBER 20, 2023
FAPI-PET imaging may become a powerful diagnostic tool for detecting pancreatic cancer, according to a study published November 16 in the Journal of Nuclear Medicine. Image courtesy of the Journal of Nuclear Medicine. Fibroblast activation protein (FAP) is overexpressed by fibroblast cells in various cancers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Imaging Technology
JUNE 29, 2023
milla1cf Thu, 06/29/2023 - 21:10 June 29, 2023 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, today announced highlights from early clinical and preclinical studies of 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1
AuntMinnie
DECEMBER 19, 2023
Clinical brain imaging with a newly developed portable PET scanner appears feasible, with a comparison to conventional PET imaging for the first time revealing similar results in human subjects, according to a group in New York City. The study was published on December 14 in the Journal of Nuclear Medicine.
AuntMinnie
OCTOBER 16, 2024
In a review of studies that included 409 patients, the technique was superior to standard-of-care FDG-PET/CT and could potentially serve as an alternative to invasive tissue sampling procedures, nuclear medicine researchers suggested.
Imaging Technology
MAY 31, 2023
Flavio Forrer , MD, PhD, Chairman of Nuclear Medicine in the Division of Radiology and Nuclear Medicine at Kantonsspital St. CR and CNR demonstrated using clinical data with inserted lesions of known size, location, and contrast. Measurement follows NEMA NU 2-2018. [v] Gallen in Switzerland [vii].
Imaging Technology
JUNE 15, 2023
The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use. Fruhwirth, G. Kneilling, M., De Vries, I. Weigelin, B.,
Expert insights. Personalized for you.
143 
Let's personalize your content